Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia.

Gungordu S., Aptullahoglu E.
Investigational new drugs , 2024 (SCI-Expanded) identifier

RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia

Aptullahoğlu E., Nakjang S., Wallıs J. P., Marr H., Marshall S., Wıllmore E., et al.
BIOMEDICINES , cilt.12, sa.7, ss.1-17, 2024 (SCI-Expanded) Creative Commons License

SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.

Aptullahoglu E., Wallis J. P., Marr H., Marshall S., Bown N., Willmore E., et al.
International journal of molecular sciences , cilt.24, sa.14, 2023 (SCI-Expanded) identifier

Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition

Aptullahoglu E., Ciardullo C., Wallis J. P., Marr H., Marshall S., Bown N., et al.
International Journal of Molecular Sciences , cilt.24, sa.3, 2023 (SCI-Expanded) identifier identifier

p53 as a biomarker and potential target in gastrointestinal stromal tumors

Wu C., Chen C., Huang W., Pan Y., APTULLAHOĞLU E., Yeh C., et al.
Frontiers in Oncology , cilt.12, 2022 (SCI-Expanded) Creative Commons License identifier identifier

In situ detection of JAK2V617F within viable hematopoietic cells using gold nanoparticle technology

Sozer S., Aptullahoglu E., Shivarov V., Yavuz A. S.
International Journal of Laboratory Hematology , cilt.41, sa.4, 2019 (SCI-Expanded) identifier identifier

Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells

Ciardullo C., Aptullahoglu E., Woodhouse L., Lin W., Wallis J. P., Marr H., et al.
Haematologica , cilt.104, sa.12, ss.2429-2442, 2019 (SCI-Expanded) identifier identifier

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma

Wu C., Esfandiari A., Ho Y., Wang N., Mahdi A. K., Aptullahoglu E., et al.
British Journal of Cancer , cilt.118, sa.4, ss.495-508, 2018 (SCI-Expanded) identifier identifier
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells

Willmore E., APTULLAHOĞLU E., Zhao Y., Kyle S., Thomas H., Ahn M., et al.
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Edinburgh, Saint Helena, 20 - 23 Eylül 2019

The spliceosome inhibitor E7107 induces a dose-dependent cytotoxicity in CLL cells and produces aberrantly spliced transcripts and protein products of p53 pathway genes

APTULLAHOĞLU E., Wallis J. P., Marr H., Marshall S., Willmore E., Lunec J.
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Edinburgh, Saint Helena, 20 - 23 Eylül 2019

E7107 treatment results in aberrantly spliced transcripts and protein products of P53 pathway genes

APTULLAHOĞLU E., Wallis J. P., Marr H., Marshall S., Willmore E., Lunec J.
The 25th Biennial Congress of the European Association for Cancer Research (EACR25), Amsterdam, Hollanda, 30 Haziran - 03 Temmuz 2018

Combined drug targeting of p53 negative regulation in cutaneous melanoma

APTULLAHOĞLU E.
Workshop On Rare Diseases, İstanbul, Türkiye, 03 Aralık 2022

Inhibition of WIP1/PPM1D phosphatase by GSK2830371 potentiates the growth inhibitory and cytotoxic activity of MDM2 antagonists (nutlin-3, RG7388 and HDM201) in cutaneous melanoma cells

Wu C., Esfandiari A., Ho Y., Shepherd C., Mahdi A. K., APTULLAHOĞLU E., et al.
(AACR) 2017 Annual Meeting, Washington, Kiribati, 1 - 05 Nisan 2017

Activation of p53 by the MDM2 Antagonist RG7388 in CLL Cells:Analysis of ExVivo Signalling, Cell Death and Gene Signature

Willmore E., Ciardullo C., APTULLAHOĞLU E., Woodhouse L., Wallis J. P., Marr H., et al.
The biennial International Workshop on Chronic Lymphocytic Leukemia, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017

The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia

Ciardullo C., Woodhouse L., APTULLAHOĞLU E., Wallis J. P., Marr H., Marshall S., et al.
58th ASH Annual Meeting Exposition, San Diego, 3 - 06 Aralık 2016, cilt.128, ss.893

Evaluating the effect of RG7388 and HDM201 as single agents in a panel of B-cell lines and CLL samples

APTULLAHOĞLU E., Ciardullo C., Wallis J. P., Marr H., Marshall S., Bown N., et al.
UK CLL Forum, Londrina, Brezilya, 05 Ekim 2016

Mineralogical and petrographical properties of the volcanic activities in the Sakarya Continent Turkey

KİBİCİ Y., YILDIZ A., İLBEYLİ N., BAĞCI M., DEMİRBİLEK M., HATİPOĞLU M., et al.
The symposium on Eartern Anatolian Geology (DAJEO’ 2015), Van, Türkiye, 7 - 11 Eylül 2015, ss.44-47

In-Cell Detection By Flow Cytometry of JAK2 V617F Mutation Using Gold Nanoflares

APTULLAHOĞLU E., Uslu I., Yavuz A. S., Shivarov V., Sozer S.
56th ASH Annual Meeting Exposition, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, ss.4586
Kitap & Kitap Bölümleri

Technical English for Bioengineering Students

APTULLAHOĞLU E.
Cinius Yayınları, İstanbul, 2022

Professional English for Molecular Biology Students

APTULLAHOĞLU E.
Cinius Yayınları, 2021